Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Sponsor content
352 result(s) found, displaying 161 to 170
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Designation or determinationOrphan drug
-
Designation or determinationPriority review
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 240 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 480 mg/24 mL concentrated injection for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 480 mg film-coated tablet blister pack.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: doravirine; lamivudine; tenofovir disoproxil fumarate.
-
Prescription medicine registrationActive ingredients: doravirine.